Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$9,083,177
+$647,559 QoQ
Shares Held
57,958
+4.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#184
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Advisors Capital Management, LLC holds $495,472,264 across 11 Drug Manufacturers - General names. NVS ranks #8 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
526,560 | $133,730,443 | |
| 2 | ABBV |
AbbVie Inc.
|
505,318 | $127,158,221 | |
| 3 | PFE |
Pfizer Inc
|
2,703,246 | $65,094,163 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
1,029,843 | $59,339,553 | |
| 5 | LLY |
ELI LILLY & Co
|
38,507 | $46,186,454 | |
| 6 | AMGN |
Amgen Inc
|
73,921 | $26,768,272 | |
| 7 | MRK |
Merck & Co., Inc.
|
179,565 | $23,074,102 | |
| 8 | NVS |
Novartis AG
This page
|
57,958 | $9,083,177 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,083,177 | 57,958 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $8,435,618 | 55,225 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $7,585,193 | 55,017 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $6,762,479 | 52,733 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $6,092,853 | 50,350 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $5,085,383 | 45,617 | Shares | Sole | 2025-05-27 | |
| 2024-12-31 | $4,222,962 | 43,397 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,957,592 | 43,102 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,549,674 | 42,736 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $3,764,731 | 38,920 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $3,750,429 | 37,144 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,796,933 | 37,276 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $3,586,543 | 35,542 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $3,166,180 | 34,415 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $2,754,622 | 30,364 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,404,880 | 31,639 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $2,445,114 | 28,926 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,367,495 | 26,980 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,007,349 | 22,949 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,778,504 | 95,115 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $8,164,246 | 89,481 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $11,719,393 | 137,101 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $12,632,089 | 133,772 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $11,128,010 | 127,967 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $11,451,322 | 131,112 | Shares | Sole | 2020-08-18 | |
| 2020-03-31 | $17,780,342 | 215,650 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||